AstraZeneca has joined other drugmakers in freezing prices in the United States for the rest of 2018, following criticism by U.S. President Donald Trump over the cost of medicine.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,